HDFC Pharma and Healthcare Fund Direct Growth

HDFC Pharma and Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by HDFC Mutual Fund. This scheme was made available to investors on 04 Oct 2023. The fund currently has an Asset Under Management(AUM) of ₹9,61,940.45 Cr and the Latest NAV as of 13 Jul 2026 is ₹21.36.
The HDFC Pharma and Healthcare Fund Direct Growth is rated Very High. Minimum SIP Investment is set to ₹100 . Minimum Lumpsum Investment is ₹100. Exit load of In respect of each purchase/Switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment..